Sarcome d’Ewing Osseux et Extra Osseux : Etude anatomo-clinique de 29 cas

##plugins.themes.academic_pro.article.sidebar##

Published May 4, 2010
Download
pdf
Vol. 88 No. 5 (2010): Issue May 2010

##plugins.themes.academic_pro.article.main##

Lobna Ayadi
Chiraz Châari
Rim Kallel
Kamel Ayadi
Abdelmajid Khabir
Rachid Jlidi
Jamel Daoud
Mounir Frikha
Saloua Makni
Laboratoire d'Anatomie et de Cytologie Pathologiques
Tahya Sellami-Boudawara

Abstract

Background: Ewing’s sarcoma (ES) is a rare tumour accounting for 10% of primary malignant bone tumours in children and 3% of all childhood malignancies. ES belongs to a group of small round cell tumours.
Aim: In this review, we will describe the main clinicopathological features of this rare tumour and discuss its prognosis.
Methods: We report a retrospective study of 29 cases of ES, of which 4 were extraosseous, diagnosed over a period 11 years (January 1989 - December 1999). Clinicopathological data were described. Hematoxylin-eosin staining and immunohistochemical study were reviewed.
Results: 12 patients were male and 17 were female (ratio: 0,8) with a median age of 16 years. 62,5% of tumours were located in flat bone and 33,3% in long bone. The medium size of the tumor was 10,6 cm (range:3-25cm). 27,5% of patients presented with metastatic disease at time of diagnosis. Microscopically, tumour tissue was composed of round, small, blue cells with fine granular chromatin. Tumour cells strongly coexpressed CD99 and vimentin (100%). Systemic treatment consisted of adjuvant chemotherapy (84,2%). Local control was based on and surgery (57,9%) or radiation therapy (36,8%). A good response to chemotherapy was obtained in 37.5%; 13,7% of patients were alive without disease (medium follow up: 169 mois); 34,5% of patients developed metastases (medium follow up : 23 months) and 10,3% developed recurrences (medium follow up :13 months).
Conclusion: Our study emphasizes two points : the great size of the tumor and the frequent location in flat bone which may explain the poor prognosis of Ewing sarcoma in our series despite the multidisciplinary treatment

Keywords:

Ewing sarcoma, bone, soft tissue, immunohistochemistry, prognosis

##plugins.themes.academic_pro.article.details##

References

  1. Ewing J. Proc. N.Y. Pathol. Soc.1921; 21: 17—24.
  2. Dorfman HD, Czerniak B. Bone cancers. Cancer1995 ; 75, (suppl 1): 203-15.
  3. Ushigome S, Machinami R, Sorensen P.H. Ewing sarcoma/ neuroectodermal tumor (PNET). In: Fletcher DM, Krishnan Unni K, Frederic Mertens. Tumours of soft tissue and bones. Pathology and genetics. World Health Organization Classification of tumours. Lyon 2002.
  4. Vlasak R, Sim FH. Ewing Sarcoma. Orthop Clin North Am1996;27:591-603.
  5. Krulik M, Brechot JM, de Saint-Maur P, Lecomte D, Mougeot-Martin M, Audebert AA, Zylberait D, Debray J.Extra skeletal Ewing's sarcoma. Report of two cases. Ultrastructural study of one case (author's transl). Sem Hop.1980;56:319-24.
  6. Mathieu E, Fain O, Nashashibi N et al. Sarcome d'Ewing extraosseux: interêt diagnostique de la biologie moléculaire. Press Med1996;25 :2046.
  7. N'Golet A, Pasquier B, Pasquier D, Lachard A, Couderc P.Extraskeletal epidural Ewing sarcoma. 2 anatomoclinical cases with review of the literature. Sem Hop1982;58:18203.
  8. Zelazny A, Reinus WR, Wilson AJ. Quantitative analysis of the plain radiographic appearance of Ewing's sarcoma of bone. Investigative Radiol1997; 32: 59-65.
  9. Pouillard P, Sastre X, Ollivier L et al. La Tumeur d'Ewing. Rev Prat1992;42 : 827-37.
  10. Siebenrock KA, Nascimento AG, Rock MG.Comparison of soft tissue Ewing's sarcoma and peripheral neuroectodermal tumor.Clin Orthop Relat Res1996;329:288-99.
  11. Shimada H, Newton WA Jr, Soule EH, Qualman SJ, Aoyama C, Maurer HM. Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study.Hum Pathol1988;19:442-53.
  12. Bernard JL, Schneiner C, Gentet JC et al. Les difficultés du diagnostic du sarcome d'Ewing. Ann pédiatrie1984;31:9.
  13. Paulussen M, Bielack S, Jürgens H, Jost L. ESMO Guidelines Working Group. Ewing's sarcoma of the bone: ESMO Clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol2008;19 (Suppl 2):ii97-8.
  14. 14- Klaassen R, Sastre Garau X, Aurias A et al. Sarcome d'Ewing osseux de l'adulte : étude de 30 observations. Cancer1992:161-67.
  15. Kissane JM, Askin FB, Fulkes M et al. Ewing's sarcoma of bone. Clinicopathologic aspects of 303 cases from intergroupe of Ewing sarcoma study.Hum Pathol1983;14: 773-79.
  16. Lombart Bosh A, Blache R, Olaya AP. Round cell sarcoma of bone and their differntial diagnosis : a study of 233 tumors with optical and electron microscopic techniques. Cancer 1992; 69: 1012-20.
  17. Lombart Bosh A, Contesso G, Peydro Olaya A et al. Histology, immunohistochemistry and electron microscopy of small round cell tumours of bone. Sem in Diag Pathol1996; 13: 153-70.
  18. Navarro S, Cavazana AO, Lombart Bosh A et al. Comparision of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunohistochemical and ultra structural analysis of two primitive neuroectodermal neoplasms. Arch Pathol Lab Med1994; 118:608-15.
  19. Lahl M, Fisher VL, Laschinger K Clin J Oncol Nurs. Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship2008;12:89-97.
  20. Delepine N, Desbois JC, Delepine G. Progrés thérapeutique récents dans le sarcome d'Ewing de l'enfant et de l'adolescent. Ann pediat1990; 37, : 579-82.
  21. Cangir A, Vietti TJ, Gehan E.A et al. Ewing sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing sarcoma studies. Cancer1990; 82: 527-30.
  22. Leavey PJ, Collier AB. Ewing sarcoma: prognostic criteria, outcomes and future treatment. Expert Rev Anticancer Ther2008; 8:617-24.
  23. Ivana Iliæ, Spomenka Manojloviæ, Mladen Æepuliæ1, Dubravko Orliæ 2, Sven Seiwerth. Osteosarcoma and Ewing's Sarcoma in Children and Adolescents: Retrospective Clinicopathological Study. Croat Med J2004; 45:740-745.